Folic acid and prevention of neural tube closure defects: The question is not solved yet;Prévention par l'acide folique des défauts de fermeture du tube neural : la question n'est toujours pas réglée

Archives de Pediatrie

Volumn 15, Issue 7, 2008, Pages 1223-1231

  Vidailhet, M ^a   Bocquet, A ^a   Bresson, J L ^a   Briend, A ^a   Chouraqui, J P ^a   Dupont, C ^a   Darmaun, D ^a   Frelut, M L ^a   Ghisolfi, J ^a   Girardet, J P ^a   Goulet, O ^a   Putet, G ^a   Rieu, D ^a   Rigo, J ^a   Turck, D ^a  

^a HÔPITAL D ENFANTS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

BREAST CANCER; COGNITIVE DEFECT; COLON ADENOMA; COLORECTAL CANCER; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; DRUG SAFETY; HEALTH PROGRAM; HUMAN; NEURAL TUBE DEFECT; PRACTICE GUIDELINE; SHORT SURVEY; STROKE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ANIMALS; BREAST NEOPLASMS; CEREALS; CLINICAL TRIALS AS TOPIC; COGNITION DISORDERS; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; FOLIC ACID; FOOD, FORTIFIED; FRANCE; HUMANS; INFANT, NEWBORN; MALE; MIDDLE AGED; NEURAL TUBE DEFECTS; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; SPINAL DYSRAPHISM; UNITED STATES;

EID: 45949091974     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2008.04.012     Document Type: Short Survey

References (63)

1. Shane B. Folate chemistry and metabolism. In: Baile L.B. (Ed). Folate in health and disease (1995), Marcel Dekker, New-York 1-22
2. McKay J.A., Williams E.A., and Mathers J.C. Folate and DNA methylation during in utero development and aging. Biochem Soc Trans 32 (2004) 1006-1007
3. Hibbard B.M. The role of folic acid in pregnancy with particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Br Commonw 71 (1964) 529-542
4. Smithells R.W., Sheppard S., and Schorah C.J. Vitamin deficiencies and neural tube defects. Arch Dis Child 51 (1976) 944-950
5. Relton C.L., Wilding C.S., Laffling A.J., et al. Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy. Mol Genet Metab 81 (2004) 273-281
6. Shane B. Folate fortification: enough already?. Am J Clin Nutr 77 (2003) 8-9
7. Rothenberg S.P., da Costa M.P., Sequeira J.M., et al. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural tube defect. N Engl J Med 350 (2004) 134-142
8. Beaudin A.E., and Stover P.J. Folate-mediated one-carbon metabolism and neural tube defects: balancing genome synthesis and gene expression. Birth Defects Res C Embryo Today 81 (2007) 183-203
9. MRC Vitamin Study Research Group. Prevention of neural tube defects : results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7.
10. Butterworth Jr. C.E., and Bendich A. Folic acid and the prevention of birth defects. Annu Rev Nutr 16 (1996) 73-97
11. Czeizel A.E., and Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327 (1992) 1832-1835
12. Rouget F., Monfort C., Bahuau M., et al. Folates en période périconceptionnelle et prévention du risque de fente orofaciale : rôle des apports alimentaires en France. Rev Epidemiol Sante Publique 53 (2005) 351-360
13. Badovinac R.L., Werler M.M., Williams P.L., et al. Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol 79 (2007) 8-15
14. Wilcox A.J., Lie R.T., Solvoll K., et al. Folic acid supplements and risk of facial clefts: national population-based control study. BMJ 334 (2007) 464
15. Canfield M.A., Collins J.S., Botto L.D., et al. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population based study. Birth Defects Res A Clin Mol Teratol 73 (2005) 679-689
16. Botto L.D., Lisi A., Bower C., et al. Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment. Birth Defects Res A Clin Mol Teratol 76 (2006) 693-705
17. American Academy of Pediatrics. Committee on Genetics. Folic acid for the prevention of neural tube defects. Pediatrics 1993;92:493-4.
18. Ward M., Hutton J., Mc Donnell R., et al. Folic acid supplements to prevent neural tube defects: trends in East of Ireland 1996-2002. Ir Med J 97 (2004) 274-276
19. Bower C., Miller M., Payne J., et al. Promotion of folate for the prevention of neural tube defects: who benefits?. Paediatr Perinat Epidemiol 19 (2005) 435-444
20. Eichholzer M., Tönz O., and Zimmermann R. Folic acid: a public-health challenge. Lancet 367 (2006) 1352-1361
21. US Food and Drug Administration. Food Standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 1996;61:8781-807.
22. Savage D.G., and Lindenbaum J. Neurological complications of acquired cobalamin deficiency: clinical aspects. Baillieres Clin Haematol 8 (1995) 657-678
23. Honein M.A., Paulozzi L.J., Mathews T.J., et al. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285 (2001) 2981-2986
24. Williams L.J., Mai C.T., Edmonds L.D., et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66 (2002) 33-39
25. De Wals P., Tairou F., Van Allen M.I., et al. Reduction in neural-tube defects after folic acid fortification. N Engl J Med 357 (2007) 135-142
26. Gucciardi E., Pietrusiak M.A., Reynolds D., et al. Incidence of neural tube defects in Ontario, 1986-1999. CMAJ 167 (2002) 237-240
27. Persad V.L., Van den Hof M.C., Dube J.M., et al. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 167 (2002) 241-245
28. Berry R.J., Li Z., Erickson D.J., et al. Prevention of neural tube defects with folic acid in China. China-US collaborative project for Neural Tube Defects Prevention. N Engl J Med 341 (1999) 1485-1490
29. Brent R.L., and Oakley Jr. G.P. Triumph and/or tragedy: the present Food and Drug Aministration program of enriching grains with folic acid. Pediatrics 117 (2006) 930-932
30. Choumenkovitch S.F., Selhub J., Wilson P.W., et al. Folic acid intake from fortification in United States exceeds predictions. J Nutr 132 (2002) 2792-2798
31. Rader J.I., and Schneeman B.O. Prevalence of neural tube defects, folate status, and folate fortification of enriched cereal-grain products in the United-States. Pediatrics 117 (2006) 1394-1399
32. Pfeiffer C.M., Caudill S.P., Gunter E.W., et al. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 82 (2005) 442-450
33. Lawrence J.M., Watkins M.L., Chiu V., et al. Food fortification with folic acid and rate of multiple births 1994-2000. Birth Defects Res A Clin Mol Teratol 70 (2004) 948-952
34. Maberly G.F., and Stanley F.J. Mandatory fortification of flour with folic acid: an overdue public health opportunity. Med J Austr 183 (2005) 342-343
35. Oakley Jr. G.P., Weber M.B., Bell K.N., et al. Scientific evidence supporting folic acid fortification of flour in Australia and New-Zealand. Birth Defects Res A Clin Mol Teratol 70 (2004) 838-841
36. Yang Q., Botto L.D., Erickson D., et al. Improvement in stroke mortality in Canada and the United- States, 1990 to 2002. Circulation 113 (2006) 1335-1343
37. Bell K.N., and Oakley Jr. G.P. Tracking the prevention of folic acid preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol 76 (2006) 654-657
38. Ducimetière P. Enrichissement de la farine en vitamines B en France. Proposition d'un programme pilote. Rapport AFSSA-INVS 2003. www.afssa.fr.
39. Programme National Nutrition Santé (PNNS). Un apport nutritionnel essentiel dans la prévention des anomalies de fermeture du tube neural. www.mangerbouger.fr.
40. Busby A., Abramsky L., Dolk H., et al. Preventing neural tube defects in Europe: a missed opportunity. Reprod Toxicol 20 (2005) 393-402
41. Kim Y.I. Does a high folate intake increase the risk of breast cancer?. Nutr Rev 64 (2006) 468-475
42. 12. Am J Clin Nutr 85 (2007) 3-5
43. Van Guelpen B., Hultdin J., Johansson I., et al. Low folate levels may protect against colorectal cancer. Gut 55 (2006) 1461-1466
44. Stolzenberg-Solomon R.Z., Chang S.C., Leitzmann M.F., et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the prostate, lung. Colorectal and Ovarian Cancer Screening Trial. Am J Clin Nutr 83 (2006) 895-904
45. Cole B.F., Baron J.A., Sandler R.S., et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297 (2007) 2351-2359
46. Ericson U., Sonestedt E., Gullberg B., et al. High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmö Diet and Cancer cohort. Am J Clin Nutr 86 (2007) 434-443
47. Knock E., Deng L., Wu Q., et al. Low dietary folate initiates intestinal tumors in mice, with altered expression of G2-M checkpoint regulators polo-like kinase 1 and cell division cycle 25c. Cancer Res 66 (2006) 10349-10356
48. Kim Y.I. Folate: a magic bullet or a double edged-sword for colorectal cancer prevention?. Gut 55 (2006) 1387-1389
49. Kim Y.I. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 51 (2007) 267-292
50. Ulrich C.M., and Potter J.D. Folate supplementation: too much of a good thing?. Cancer Epidemiol Biomarkers Prev 15 (2006) 189-193
51. Mason J.B., Dickstein A., Jacques P.F., et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 16 (2007) 1325-1329
52. Durga J., van Boxtel M.P., Schouten E.G., et al. Effect of a 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind controlled trial. Lancet 369 (2007) 208-216
53. 12 intake and cognitive decline among community-dwelling older persons. Arch Neurol 62 (2005) 641-645
54. 12 status in relation to anemia, macrocytosis and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 85 (2007) 193-200
55. Botto L.D., Lisi A., Robert-Gnansia E., et al. International retrospective study of neural tube defects in relation to folic acid recommendations: are the recommendations working?. BMJ 330 (2005) 571
56. Stoll C., Alembik Y., and Dott B. Are the recommendations on the prevention of neural tube defects working?. Eur J Med Genet 49 (2006) 461-465
57. Wald N.J., and Oakley G.P. Should folic acid fortification be mandatory? Yes. BMJ 334 (2007) 1252
58. Hubner R.A., Houlston R.D., and Muir K.R. Should folic acid fortification be mandatory? No. BMJ 334 (2007) 1253
59. Conlin M.L., Mac Lennan A.H., and Broadbent J.L. Inadequate compliance with periconceptional folic acid supplementation in South Australia. Aust NZ J Obstet Gynaecol 46 (2006) 528-533
60. Green-Raleigh K., Carter H., Mulinare J., et al. Trends in folic acid awareness and behavior in the United-States: the Gallup organization for the March of Dimes foundation surveys, 1995-2005. Matern Child Health J 10 (2006) S177-S182
61. Robbins J.M., Cleves M.A., Collins H.B., et al. Randomized trial of a physician-based intervention to increase the use of folic acid supplements among women. Am J Obstet Gynecol 192 (2005) 1126-1132
62. Williams J.L., Abelman S.M., Fassett E.M., et al. Health care provider knowledge and practices regarding folic acid, United States 2002-2003. Matern Child Health J 10 (2006) S67-72
63. Power M.L., Holzman G.B., and Schulkin J. Knowledge and clinical practice regarding folic acid among obstetricians-gynecologists. Obstet Gynecol 95 (2000) 895-898